TP
PERM FY2024-FY2025NAICS 325412
Takeda Pharmaceuticals USA, Inc. PERM Filings
Public PERM filing activity, approval signal, filed wage evidence, beneficiary countries, law firms, and role mix for Takeda Pharmaceuticals USA, Inc..
Updated 2026-05-23
PERM filings
16records
Approval rate
68.8%FY2024-FY2025
Median filed wage
$142,000base wage
Denied filings
0PERM records
Top country
N/A
LCA filings are not visa approvals or open roles — see why this matters
Public filing data is normalized for browsing. LCA filings are not visa approvals or job openings, PERM filings are not individual green-card success rates, and salary figures generally use the lower bound of filed wage ranges and exclude equity, bonus, and benefits. PERM pages describe employer filing activity and should not be read as legal advice or a prediction of an individual case outcome.
Top PERM roles
- Manager, GI Rare Data Analytics1$140,500
- Associate Director - Strategic Procurement Manager1$143,500
- Platform Architect1$140,500
- Patient Insights & Analytics Lead1$130,200
- Senior Analyst, Data Insights & Analytics1$98,900
- Senior Counsel, Data, Technology & Innovation1$258,523
- Quality Control Manager1$176,000
- Director Global Oncology Forecasting1$240,200
Top law firms
- Zulkie Partners LLC16
Frequently Asked Questions
How many PERM filings does Takeda Pharmaceuticals USA, Inc. have?
Takeda Pharmaceuticals USA, Inc. has 16 PERM filings in the available FY2024-FY2025 dataset.
What is the PERM approval rate for Takeda Pharmaceuticals USA, Inc.?
The observed PERM approval rate for Takeda Pharmaceuticals USA, Inc. is 68.8% based on certified and denied filings in the available dataset.
Which PERM roles appear most often for Takeda Pharmaceuticals USA, Inc.?
Common PERM roles for Takeda Pharmaceuticals USA, Inc. include Manager, GI Rare Data Analytics, Associate Director - Strategic Procurement Manager, Platform Architect.
Which beneficiary countries appear most often in Takeda Pharmaceuticals USA, Inc. PERM filings?
The available PERM profile for Takeda Pharmaceuticals USA, Inc. does not expose enough country concentration for a top-country summary.